Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer - Concepedia

Concepedia

Publication | Open Access

Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer

DOI Full Paper Access

34

Citations

22

References

2020

Year

Foyez Mahmud, Shanshan Deng, Hao Chen, Duane D. Miller, Wěi Li

Paclitaxel-resistant Lung CancerMedicinePharmacologyAntitumor EfficacyBronchial NeoplasmAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyLung Cancer

References

	Year	Citations

Page 1